CS
NUVL

Candriam SCA’s Nuvalent NUVL Stock Holding History

Candriam SCA’s Portfolio NUVL Stock Details NUVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.26M Sell
18,336
-372,970
-95% -$40.1M 0.01% 497
2026
Q1 		$40.1M Buy
391,306
+33,293
+9% +$3.39M 0.21% 105
2025
Q4 		$36M Buy
358,013
+28,292
+9% +$2.79M 0.18% 125
2025
Q3 		$28.5M Buy
329,721
+28,462
+9% +$2.25M 0.15% 138
2025
Q2 		$23M Sell
301,259
-52,870
-15% -$3.87M 0.13% 148
2025
Q1 		$25.1M Sell
354,129
-13,966
-4% -$1.09M 0.16% 136
2024
Q4 		$28.8M Buy
368,095
+49,728
+16% +$4.64M 0.17% 123
2024
Q3 		$32.6M Buy
318,367
+56,359
+22% +$4.67M 0.19% 118
2024
Q2 		$19.9M Sell
262,008
-22,001
-8% -$1.56M 0.12% 170
2024
Q1 		$21.3M Buy
284,009
+4,000
+1% +$318K 0.14% 158
2023
Q4 		$20.6M Sell
280,009
-70,008
-20% -$4.33M 0.14% 157
2023
Q3 		$16.1M Buy
350,017
+70,001
+25% +$3.11M 0.11% 171
2023
Q2 		$11.8M Sell
280,016
-43,835
-14% -$1.66M 0.09% 224
2023
Q1 		$7.78M Buy
323,851
+65,202
+25% +$1.93M 0.05% 294
2022
Q4 		$7.7M Buy
+258,649
New +$7.21M 0.05% 316

Other funds holding NUVL

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Candriam SCA's NUVL Position: Q2 2026 in Review

Candriam SCA reduced its Nuvalent (NUVL) stake by 95% in Q2 2026, selling an estimated $40.1M and leaving 18,336 shares worth $2.26M. The position accounts for 0.01% of the portfolio, ranked #497.

Candriam SCA first reported a position in NUVL in Q4 2022 and has held it in 15 quarters since. The position peaked at $40.1M in Q1 2026. 293 funds tracked by Wall St. Rank hold NUVL as of Q2 2026.

  • Candriam SCA held 18,336 shares of Nuvalent worth $2.26M as of Q2 2026.
  • Candriam SCA sold 372,970 Nuvalent shares in Q2 2026, an estimated $40.1M.
  • Nuvalent made up 0.01% of Candriam SCA's portfolio in Q2 2026, its #497 holding.
  • Candriam SCA first reported a position in Nuvalent in Q4 2022 and has held it in 15 quarters since.
  • Candriam SCA's Nuvalent position peaked at $40.1M in Q1 2026.
  • 293 funds tracked by Wall St. Rank held Nuvalent as of Q2 2026.

Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.